Dimension Capital II, L.P. bought $20.0M of Odyssey Therapeutics (ODTX)

Executed May 8, disclosed May 12, 4 days later.

Value, as filed

$20.0M

1,111,111 sh × $18.00

Executed

May 8

the trade date, as filed

Disclosed

May 12

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

-8.0%

-14.4% from execution

Over the 21 trading sessions from the disclosed entry session (May 12), the stock returned -8.0% (delay-adjusted); from the execution session (May 8), -14.4%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

DP Dimension Capital II, L.P. Director profile →

Dimension Capital II, L.P. (Director) filed 1 Form 4 report as a reporting entity in the trailing twelve months (1 purchase, 0 sales), most often in ODTX. Across 1 priced purchase filing, the average 21-session return was -14.4% from execution and -8.0% from disclosure (delay-adjusted; derived). The largest single filing was $20.0M of ODTX (1,111,111 sh × $18.00, as filed), executed May 8.

The name

ODTX ODTX ODTX · 6 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→